CRISPR disruption of NRF2 re-sensitises tumours to chemo

Written by

admin

in

Researchers have shown that using CRISPR to disable the NRF2 gene can restore chemotherapy sensitivity and slow tumour growth.


Scientists at ChristianaCare’s Gene Editing Institute have reported a new discovery in cancer…

Continue Reading

More posts